The binding of antibiotics and drugs to DNA is a fast developing area of
research with important applications in medicine, particularly the treatment of
cancer. Sequence-specific DNA Binding Agents uniquely discusses key aspects of
this topic, providing a novel perspective on the subject. Written by experts in
the field, this book discusses diverse modes of binding of antibiotics and drugs
to DNA, emphasising matters that are important or promising for cancer
treatment. Chapters discuss established agents like actinomycin D but also look
at novel drugs with strong potential in chemotherapy such as new topoisomerase
inhibitors, telomerase inhibitors, peptide nucleic acids and triple
helix-forming oligonucleotides. There are also sections